Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide
Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmona...
Saved in:
| Published in | The clinical respiratory journal Vol. 12; no. 2; pp. 595 - 600 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
John Wiley & Sons, Inc
01.02.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1752-6981 1752-699X 1752-699X |
| DOI | 10.1111/crj.12568 |
Cover
| Abstract | Objective
Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.
Methods
The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.
Result
Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25‐75). There was a significant decrease in FEF25‐75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi‐factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88‐13.49).
Conclusion
CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies. |
|---|---|
| AbstractList | Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.
The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.
Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49).
CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies. Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Result Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25‐75). There was a significant decrease in FEF25‐75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi‐factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88‐13.49). Conclusion CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies. Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Result Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n=52) and a normal FeNO group (FeNO lower than 25 ppb, n=47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR=5.03, 95% CI, 1.88-13.49). Conclusion CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies. Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.OBJECTIVECough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.METHODSThe clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49).RESULTNewly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49).CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.CONCLUSIONCVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies. |
| Author | Miao, Lili Tang, Wei Zhou, Jun Shi, GuoCao |
| Author_xml | – sequence: 1 givenname: Wei surname: Tang fullname: Tang, Wei organization: Shanghai Jiaotong University School of Medicine – sequence: 2 givenname: Jun surname: Zhou fullname: Zhou, Jun organization: Shanghai Jiaotong University School of Medicine – sequence: 3 givenname: Lili surname: Miao fullname: Miao, Lili organization: Yi Zheng People's Hospital – sequence: 4 givenname: GuoCao surname: Shi fullname: Shi, GuoCao email: shiguochao@hotmail.com organization: Shanghai Jiaotong University School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27731932$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1vFCEYh4mpsR968B8wJF70sC0fOwwczaZWmyYmjSbeyLsM47BhYAWmH_99me7WQ1O5wOF5frx5f8foIMRgEXpPySmt58ykzSlljZCv0BFtG7YQSv0--PeW9BAd57whpJEtb96gQ9a2nCrOjlBeeRecAY97C2VKNmMX8BaKs6FkHHts4vRnwDeQHISCIZdhBHzryoBDTGMVIXR4cJXx9sb6WbF3A3jb4T6BKS6GCgVXkjM43rnOvkWve_DZvtvfJ-jX1_Ofq2-Lqx8X31dfrhaGN1wuVMdkt2ZGqKYRgtaBJYHGECmFsr0ykgrTK94C42a5Zk0nekJpB-1SEbtuDT9Bn3a52xT_TjYXPbpsrPcQbJyypnL-p5WcV_TjM3QTp1QHz5oRwoiQSzVTH_bUtB5tp7fJjZDu9dM6K3C2A0yKOSfba-MKzCsoCZzXlOi5MF0L04-FVePzM-Mp9CV2n37rvL3_P6hX15c74wFiX6RP |
| CitedBy_id | crossref_primary_10_1002_alr_23090 crossref_primary_10_1080_02770903_2019_1568452 crossref_primary_10_1155_2021_6694936 crossref_primary_10_1186_s13223_019_0318_5 crossref_primary_10_1097_MD_0000000000026416 crossref_primary_10_1080_00914037_2019_1596917 crossref_primary_10_3389_fmed_2021_727381 crossref_primary_10_4168_aair_2019_11_6_830 |
| Cites_doi | 10.1016/j.niox.2014.06.001 10.1183/09031936.00202413 10.1378/chest.12-0441 10.1164/rccm.9120-11ST 10.1056/NEJM197903223001201 10.1016/j.pupt.2008.12.001 10.3109/02770903.2013.878953 10.1016/j.rmed.2008.04.018 10.4168/aair.2016.8.1.12 10.1378/chest.10-0132 10.1016/j.jaci.2014.10.026 10.1159/000355706 10.1016/S0140-6736(08)61420-8 10.1164/rccm.200609-1346OC 10.1186/1465-9921-8-82 10.1152/physrev.00034.2003 10.1111/j.1600-065X.2011.01032.x 10.1016/j.rmed.2012.10.003 10.2500/aap.2007.28.2920 |
| ContentType | Journal Article |
| Copyright | 2016 John Wiley & Sons Ltd 2016 John Wiley & Sons Ltd. Copyright © 2018 John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2016 John Wiley & Sons Ltd – notice: 2016 John Wiley & Sons Ltd. – notice: Copyright © 2018 John Wiley & Sons Ltd |
| DBID | AAYXX CITATION NPM K9. 7X8 |
| DOI | 10.1111/crj.12568 |
| DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1752-699X |
| EndPage | 600 |
| ExternalDocumentID | 27731932 10_1111_crj_12568 CRJ12568 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OC 24P 29B 31~ 3SF 4.4 50Y 50Z 52M 52O 52S 52T 52U 52V 52W 53G 5HH 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAMMB AANHP AAONW AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ACAHQ ACBWZ ACCMX ACGFS ACMXC ACPOU ACRPL ACUHS ACXQS ACYXJ ADBBV ADEOM ADIYS ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZMN AEFGJ AEIMD AENEX AFBPY AFGKR AFKRA AGQPQ AGXDD AHMBA AIACR AIDQK AIDYY AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN ESX F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA GROUPED_DOAJ H.X HF~ HMCUK HVGLF HZ~ KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 NF~ O66 O9- OIG OK1 OVD OVEED P2W P2X P2Z P4D PQQKQ Q.N QB0 R.K ROL RPM RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WVDHM XG1 ZZTAW ~IA ~WT AAYXX CITATION PHGZM 33P AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE NPM K9. 7X8 |
| ID | FETCH-LOGICAL-c3538-9d28db2c695566131980a5c08869ef9c816cf937a23c4b25d6f011da7490eb7c3 |
| ISSN | 1752-6981 1752-699X |
| IngestDate | Thu Oct 02 10:27:43 EDT 2025 Tue Oct 07 06:06:55 EDT 2025 Wed Feb 19 02:43:13 EST 2025 Wed Oct 01 02:57:02 EDT 2025 Thu Apr 24 22:57:21 EDT 2025 Wed Aug 20 07:24:35 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | exhaled fractional nitric oxide allergic rhinitis cough variant asthma FEF25-75 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2016 John Wiley & Sons Ltd. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3538-9d28db2c695566131980a5c08869ef9c816cf937a23c4b25d6f011da7490eb7c3 |
| Notes | All the authors do not have any potential conflicts of interests. Wei Tang and Jun Zhou contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| PMID | 27731932 |
| PQID | 2002068493 |
| PQPubID | 946373 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1835387833 proquest_journals_2002068493 pubmed_primary_27731932 crossref_citationtrail_10_1111_crj_12568 crossref_primary_10_1111_crj_12568 wiley_primary_10_1111_crj_12568_CRJ12568 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | February 2018 2018-02-00 2018-Feb 20180201 |
| PublicationDateYYYYMMDD | 2018-02-01 |
| PublicationDate_xml | – month: 02 year: 2018 text: February 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Copenhagen |
| PublicationTitle | The clinical respiratory journal |
| PublicationTitleAlternate | Clin Respir J |
| PublicationYear | 2018 |
| Publisher | John Wiley & Sons, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc |
| References | 2007; 28 2004; 84 1979; 200 2015; 135 2010; 138 2007; 176 2013; 107 2007; 8 2009; 7 2013; 143 2008; 102 2009; 2 2014; 40 2011; 184 2014; 51 2008; 372 2016; 8 2014; 44 2011; 242 2014; 87 e_1_2_10_12_1 e_1_2_10_23_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_10_1 e_1_2_10_21_1 e_1_2_10_11_1 e_1_2_10_22_1 e_1_2_10_20_1 Chinese Medical A. (e_1_2_10_8_1) 2009; 7 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 |
| References_xml | – volume: 8 start-page: 82 year: 2007 article-title: Factors affecting exhaled nitric oxide measurements: the effect of sex publication-title: Respir Res. – volume: 84 start-page: 731 year: 2004 end-page: 765 article-title: Nitric oxide in health and disease of the respiratory system publication-title: Physiol Rev. – volume: 138 start-page: 1418 issue: 6 year: 2010 end-page: 1425 article-title: Inflammatory subtypes in cough‐variant asthma: association with maintenance doses of inhaled corticosteroids publication-title: Chest. – volume: 176 start-page: 238 year: 2007 end-page: 242 article-title: Reference ranges for exhaled nitric oxide derived from a random community survey of adults publication-title: Am J Respir Crit Care Med. – volume: 28 start-page: 74 issue: 1 year: 2007 end-page: 78 article-title: Role of forced expiratory flow at 25‐75% as an early marker of small airways impairment in subjects with allergic rhinitis publication-title: Allergy Asthma Proc. – volume: 200 start-page: 633 year: 1979 end-page: 637 article-title: Chronic cough as the sole presenting manifestation of bronchial asthma publication-title: N Engl J Med. – volume: 102 start-page: 1452 year: 2008 end-page: 1459 article-title: Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough publication-title: Respir Med. – volume: 51 start-page: 411 issue: 4 year: 2014 end-page: 416 article-title: FENO and AHR mannitol in patients referred to an out‐of‐hospital asthma clinic: a real‐life study publication-title: J Asthma. – volume: 372 start-page: 1015 issue: 9643 year: 2008 end-page: 1017 article-title: Exhaled nitric oxide in guideline‐based asthma management publication-title: Lancet. – volume: 143 start-page: 613 issue: 3 year: 2013 end-page: 620 article-title: A prospective, multicenter survey on causes of chronic cough in China publication-title: Chest. – volume: 2 start-page: 114 issue: 2 year: 2009 end-page: 120 article-title: Eosinophilic airway disorders associated with chronic cough publication-title: Pulmon Pharmacol Therap. – volume: 102 start-page: 1452 issue: 10 year: 2008 end-page: 1459 article-title: Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough publication-title: Respir Med. – volume: 135 start-page: 877 issue: 4 year: 2015 end-page: 883 article-title: Biomarker‐based asthma phenotypes of corticosteroid response publication-title: J Allergy Clin Immunol. – volume: 107 start-page: 209 issue: 2 year: 2013 end-page: 216 article-title: FENO measurement and sputum analysis for diagnosing asthma in clinical practice publication-title: Respir Med. – volume: 40 start-page: 87 year: 2014 end-page: 91 article-title: Predictive value of fractional nitric oxide in asthma diagnosis‐subgroup analyses publication-title: Nitric Oxide. – volume: 7 start-page: 453 issue: 5 year: 2009 end-page: 456 article-title: Diagnosis and treatment guideline of cough publication-title: Clin Educ Gen Pract (Chin). – volume: 184 start-page: 602 issue: 5 year: 2011 end-page: 615 article-title: An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications publication-title: Am J Respir Crit Care Med. – volume: 44 start-page: 351 issue: 2 year: 2014 end-page: 360 article-title: Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitis and asthma in the EGEA study publication-title: Eur Respir J. – volume: 87 start-page: 211 issue: 3 year: 2014 end-page: 218 article-title: Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma publication-title: Respiration. – volume: 8 start-page: 12 issue: 1 year: 2016 end-page: 21 article-title: Exhaled NO: determinants and clinical application in children with allergic airway disease publication-title: Allergy Asthma Immunol Res. – volume: 242 start-page: 220 issue: 1 year: 2011 end-page: 232 article-title: Human asthma phenotypes: from the clinic, to cytokines, and back again publication-title: Immunol Rev. – ident: e_1_2_10_4_1 doi: 10.1016/j.niox.2014.06.001 – ident: e_1_2_10_20_1 doi: 10.1183/09031936.00202413 – ident: e_1_2_10_2_1 doi: 10.1378/chest.12-0441 – ident: e_1_2_10_11_1 doi: 10.1164/rccm.9120-11ST – ident: e_1_2_10_9_1 doi: 10.1056/NEJM197903223001201 – ident: e_1_2_10_3_1 doi: 10.1016/j.pupt.2008.12.001 – ident: e_1_2_10_16_1 doi: 10.3109/02770903.2013.878953 – volume: 7 start-page: 453 issue: 5 year: 2009 ident: e_1_2_10_8_1 article-title: Diagnosis and treatment guideline of cough publication-title: Clin Educ Gen Pract (Chin). – ident: e_1_2_10_12_1 doi: 10.1016/j.rmed.2008.04.018 – ident: e_1_2_10_10_1 – ident: e_1_2_10_19_1 doi: 10.4168/aair.2016.8.1.12 – ident: e_1_2_10_14_1 doi: 10.1378/chest.10-0132 – ident: e_1_2_10_5_1 doi: 10.1016/j.jaci.2014.10.026 – ident: e_1_2_10_22_1 doi: 10.1159/000355706 – ident: e_1_2_10_6_1 doi: 10.1016/S0140-6736(08)61420-8 – ident: e_1_2_10_18_1 doi: 10.1164/rccm.200609-1346OC – ident: e_1_2_10_21_1 doi: 10.1186/1465-9921-8-82 – ident: e_1_2_10_7_1 doi: 10.1152/physrev.00034.2003 – ident: e_1_2_10_17_1 doi: 10.1016/j.rmed.2008.04.018 – ident: e_1_2_10_13_1 doi: 10.1111/j.1600-065X.2011.01032.x – ident: e_1_2_10_15_1 doi: 10.1016/j.rmed.2012.10.003 – ident: e_1_2_10_23_1 doi: 10.2500/aap.2007.28.2920 |
| SSID | ssj0058735 |
| Score | 2.1614203 |
| Snippet | Objective
Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in... Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients... Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 595 |
| SubjectTerms | allergic rhinitis Asthma cough variant asthma exhaled fractional nitric oxide FEF25‐75 Nitric oxide |
| Title | Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcrj.12568 https://www.ncbi.nlm.nih.gov/pubmed/27731932 https://www.proquest.com/docview/2002068493 https://www.proquest.com/docview/1835387833 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1752-699X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0058735 issn: 1752-6981 databaseCode: ABDBF dateStart: 20070701 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVOVD databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling customDbUrl: eissn: 1752-699X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0058735 issn: 1752-6981 databaseCode: OVEED dateStart: 20070701 isFulltext: true titleUrlDefault: http://ovidsp.ovid.com/ providerName: Ovid |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLaGqYS4IHYGCjKIA1KVynESxzm2A1VVaThAK3qLvEUdaZqgWVDFf-A_82wnToa2UuESRYk9duZ9fov9FoQ-SKIrJhSPKk54lFa5iLiiWSTAZtZcEkmENRRnX9jxWXpynp2PRr8HXkubtdxXv26MK_kfqsIzoKuNkv0HyoYfhQdwD_SFK1AYrnei8bQLa6yMy8_pfcJ9ptSVdxi3NXh-gj0srCv5an1xKfzWa211VZ8mwGYs3ltY5yHbxVxdgMzQe9XShzxAI1j11t--uZrrLcchC7EQWbkcnNkPJ-92BTxD-W7m_T51s_FBIQGcs7lo_C7BIjT75koOA46bqWiGGxQx73yaA0_NMxqxwldm2TfDZ66Kbs-I6QBwdMBVM1-HsxXQzKU2vY33qyVwf9DjeC_gukP9v-Re8Ebs7CDoWrqu99AOBSFBxmjn4PDT4VEn2jOeu4qt4YvaVFXWNSyMu63gXLNato0gp8WcPkIPW_MDH3gsPUYjUz9B92etg8VTtOoghTtI4XmNO0jhpsIOUriFFPaQwhZS2EMKA6SwhRR2kLJdWkjhHlLYQwo7SD1DZ0efT6fHUVuXI1KJk4-aci2pYkUGxkAMTJwTkSmQV6wwVaF4zFQFaq-giUolzTSrQIpokacFMTJXyXM0rpvavERYJ1XCiTRxplXKEiJjW19eFkozJYhKJ-hj92eWqk1ab2unLMprRJug96HpD5-p5aZGux1FynYtrGwlVkoYT4tkgt6F18Bm7dmZqE2zWZUg-eDTc55AmxeekmEUmueJtYNgso60tw9fTr-euJtXd5nsa_SgX0-7aLxebswbUIHX8m0LzD-937PW |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+features+in+patients+of+cough+variant+asthma+with+normal+and+high+level+of+exhaled+fractional+nitric+oxide&rft.jtitle=The+clinical+respiratory+journal&rft.au=Tang%2C+Wei&rft.au=Zhou%2C+Jun&rft.au=Miao%2C+Lili&rft.au=Shi%2C+GuoCao&rft.date=2018-02-01&rft.issn=1752-6981&rft.eissn=1752-699X&rft.volume=12&rft.issue=2&rft.spage=595&rft.epage=600&rft_id=info:doi/10.1111%2Fcrj.12568&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_crj_12568 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1752-6981&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1752-6981&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1752-6981&client=summon |